F

Fennec Pharmaceuticals
D

FENC

8.00000
USD
-0.22
(-2.68%)
مغلق
حجم التداول
5,263
الربح لكل سهم
1
العائد الربحي
-
P/E
-31
حجم السوق
273,227,968
المقالات

العنوان: Fennec Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.